Xin Y. Gao

Holistic Medicine
429 N Chapel Ave Apt A, 
Alhambra, CA 
Clinical Trials:Currently Recruiting for 1 Trial
429 N Chapel Ave Apt A, 
Alhambra, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Xin Gao is a Holistic Medicine provider in Alhambra, California. Her top areas of expertise are Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Venous Thromboembolism (VTE), Angioplasty, and Endoscopy.

Her clinical research consists of co-authoring 464 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Holistic Medicine
Licenses
Acupuncturist in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

429 N Chapel Ave Apt A, Alhambra, CA 91801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A First-in-Human, Multicenter, Open-Label, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB004 as Monotherapy and in Combination With Toripalimabin Subjects With Advanced Solid Malignancies Including Lymphoma
A First-in-Human, Multicenter, Open-Label, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB004 as Monotherapy and in Combination With Toripalimabin Subjects With Advanced Solid Malignancies Including Lymphoma
Enrollment Status: Recruiting
Publish Date: February 05, 2024
Intervention Type: Drug
Study Drugs: TAB004, Toripalimab
Study Phase: Phase 1
A Phase I/Ib, Open-label, Multi-center Study of DFF332 as a Single Agent and in Combination With Everolimus or IO Agents in Patients With Advanced/Relapsed ccRCC and Other Malignancies With HIF2α Stabilizing Mutations
A Phase I/Ib, Open-label, Multi-center Study of DFF332 as a Single Agent and in Combination With Everolimus or IO Agents in Patients With Advanced/Relapsed ccRCC and Other Malignancies With HIF2α Stabilizing Mutations
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: DFF332, RAD001, PDR001, NIR178
Study Phase: Phase 1
An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1 Study of LY3434172, a Bispecific Antibody Monotherapy in Advanced Solid Tumors
A Phase 1 Study of LY3434172, a Bispecific Antibody Monotherapy in Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: January 15, 2025
Intervention Type: Drug
Study Phase: Phase 1
Phase 2 Trial of Tremelimumab in Patients With Metastatic Urothelial Cancer Previously Treated With PD-1/PD-L1 Blockade
Phase 2 Trial of Tremelimumab in Patients With Metastatic Urothelial Cancer Previously Treated With PD-1/PD-L1 Blockade
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Tremelimumab
Study Phase: Phase 2
A Phase 2 Study of Neratinib in Patients With Metastatic Castration Resistant Prostate Cancer and Increased Human Epithelial Growth Factor Receptor 2 (HER2) Signaling
A Phase 2 Study of Neratinib in Patients With Metastatic Castration Resistant Prostate Cancer and Increased Human Epithelial Growth Factor Receptor 2 (HER2) Signaling
Enrollment Status: Withdrawn
Publish Date: July 11, 2023
Intervention Type: Drug
Study Drug: Neratinib
Study Phase: Phase 2
View 5 Less Clinical Trials

463 Total Publications

Strategies reimagined: SDG-driven solutions for combating global desertification.
Strategies reimagined: SDG-driven solutions for combating global desertification.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 29, 2025
Similar Doctors
Expertise in
4
conditions
Jin W. Chang
Holistic Medicine
Expertise in
4
conditions
Jin W. Chang
Holistic Medicine
2270 Venice Blvd, 
Los Angeles, CA 
 (11.1 miles away)
951-616-8780
Languages Spoken:
English

Jin Chang is a Holistic Medicine provider in Los Angeles, California. Mr. Chang is highly rated in 4 conditions, according to our data. His top areas of expertise are Arteriovenous Malformation, Sheehan Syndrome, Thalamotomy, and Gamma Knife Radiosurgery.

Expertise in
3
conditions
Peter R. Galle
Holistic Medicine
Expertise in
3
conditions
Peter R. Galle
Holistic Medicine
566 S San Vicente Blvd, 
Los Angeles, CA 
 (14.3 miles away)
704-577-8657
Languages Spoken:
English

Peter Galle is a Holistic Medicine provider in Los Angeles, California. Mr. Galle is highly rated in 3 conditions, according to our data. His top areas of expertise are Liver Failure, Gallbladder Disease, Endoscopy, and Colonoscopy.

Expertise in
2
conditions
Steve S. Liu
Holistic Medicine
Expertise in
2
conditions
Steve S. Liu
Holistic Medicine
4050 Temple City Blvd, 
Rosemead, CA 
 (4.2 miles away)
626-242-5658
Languages Spoken:
English

Steve Liu is a Holistic Medicine provider in Rosemead, California. Mr. Liu is highly rated in 2 conditions, according to our data. His top areas of expertise are Hip Replacement and Knee Replacement.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gao's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile